Skip to main content

Table 3 HLA-type for donor and patients

From: Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma

HLA-type

HLA-A

HLA-B

HLA-DR

Donor

A2,24

B15,44

DR1,4

Patient 1

A2

B51,60

DR13

Patient 2

A2

B15,27

DR3,4

Patient 3

A2,3

B8,44

DR3,4

Patient 4

A3,32

B7,44

DR12,15

Patient 5

A1,29

B44

DR7,13

Patient 6

A2,11

B7,60

DR4,13

Patient 7

A26,32

B51,62

DR4

Patient 8

A1,24

B8,18

DR3,13

Patient 9

A2,3

B7,51

DR1,15

Patient 10

A24,29

B35,44

DR7,13

Patient 11

A2,24

B27,51

DR11,12

Patient 12

A2,24

B7

DR4,5